Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Solid Tumors Clinical Trial
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Greenville Hospital System University Medical Center (ITOR)
mi
from
Greenville, SC
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Vincent's/Peter Mac
mi
from
Fitzroy,
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Health System
mi
from
Neptune, NJ
Click here to add this to my saved trials
Cancer Clinical Trial
GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)
Status: Enrolling, Phase I
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
TriHealth Hatton Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Florida Hematology and Oncology Centers
mi
from
Orange City, FL
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Wellmont Medical Associates-Bristol
mi
from
Bristol, VA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Grand Valley Oncology
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
WVUH-Berkely Medical Center
mi
from
Martinsburg, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
North Shore Hem Onc Associates
mi
from
East Setauket, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Arizona Cancer Center at Dignity Health; St. Josephs Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Treatment Centers of America-Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Comprehensive Cancer Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)
Status: Enrolling, Phase III
Updated: 7/28/2016
MSD Brasil
mi
from
Sao Paulo,
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
Status: Enrolling, Phase I, II
Updated: 12/26/2017
LSU Health New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Advanced Solid Tumours Clinical Trial
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigational Pharmacy, Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt Health Pharmacy One Hundred Oaks
mi
from
Nashville, TN
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University Oncology Pharmacy
mi
from
Nashville, TN
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northville Health Center
mi
from
Northville, MI
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Status: Enrolling, Phase II
Updated: 12/31/1969
UCSD Medical Center - Vista
mi
from
Vista, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling, Phase I
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Advance Oncology Center
mi
from
Aguadilla,
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Wisconsin Cancer Center
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Dell Seton Medical Center at The University of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Crozer-Keystone Regional Cancer Center at Broomall
mi
from
Broomall, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Mills-Peninsula Medical Center
mi
from
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Golden Triangle
mi
from
Columbus, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Palo Alto Medical Foundation-Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Garden City
mi
from
Garden City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Health Care Germantown Health Center
mi
from
Germantown, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
AMITA Health Cancer Institute and Outpatient Center
mi
from
Hinsdale, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Vidant Oncology-Kenansville
mi
from
Kenansville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph London
mi
from
London, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Bay Area Medical Group-Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Monticello Cancer Center
mi
from
Monticello, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Chancellor Center for Oncology
mi
from
Newburgh, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Providence Hospitals - Novi
mi
from
Novi, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Presbyterian Rust Medical Center/Jorgensen Cancer Center
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Christian Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital South
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Sandstone
mi
from
Sandstone, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Warren Hospital
mi
from
Warren, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Susquehanna
mi
from
Williamsport, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Elizabeth Youngstown Hospital
mi
from
Youngstown, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Akron General
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lovelace Medical Center-Saint Joseph Square
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Duluth Clinic Ashland
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern Medicine Cancer Center Kishwaukee
mi
from
DeKalb, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Cancer Center - Elk Grove
mi
from
Elk Grove, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northeast Georgia Medical Center-Gainesville
mi
from
Gainesville, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale-New Haven Shoreline Medical Center
mi
from
Guilford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UP Health System Hematology Oncology Marquette
mi
from
Marquette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UH Seidman Cancer Center at Southwest General Hospital
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials